Daniel Janney, Director at Krystal Biotech, Inc. (KRYS), sold 65,000 shares at $129.29 ($8.3M) on 2023-06-09, disclosed to the SEC on 2023-06-09.
Open-market sale of $8.3M KRYS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $127.86 | 5,000 | $639K | 7.7% |
| 2 | $127.96 | 10,000 | $1.3M | 15.3% |
| 3 | $127.96 | 4,604 | $589K | 7.1% |
| 4 | $127.96 | 4,604 | $589K | 7.1% |
| 5 | $127.96 | 5,000 | $640K | 7.7% |
| 6 | $128.73 | 5,388 |
| $694K |
| 8.3% |
| 7 | $128.73 | 5,388 | $694K | 8.3% |
| 8 | $129.02 | 1,073 | $138K | 1.7% |
| 9 | $129.02 | 1,073 | $138K | 1.7% |
| 10 | $128.53 | 10,000 | $1.3M | 15.4% |
| 11 | $128.84 | 5,000 | $644K | 7.7% |
| 12 | $129.29 | 3,935 | $509K | 6.1% |
| 13 | $129.29 | 3,935 | $509K | 6.1% |
| Total | $128.43 avg | 65,000 | $8.3M | 100% |
| Filing → |
| KRYS | SELL | 2023-05-23 | $4.8M | — | Filing → |
| KRYS | SELL | 2023-05-11 | $1.6M | — | Filing → |
| KRYS | SELL | 2023-04-21 | $714K | — | Filing → |